Publication | Closed Access
Stratum Corneum Abnormalities and Disease-Affected Skin: Strategies for Successful Outcomes in Inflammatory Acne.
11
Citations
0
References
2016
Year
InflammationAutoimmune DiseaseAllergyStratum CorneumCutaneous BiologyDisease-affected SkinTopical DrugClinical DermatologyScar PreventionSkin PharmacologyWound HealingDermatologyDermatopathologyExperimental DermatologyMedicineStratum Corneum AbnormalitiesPatient ComplianceInflammatory Acne
Stratum corneum (SC) abnormalities are associated with disease-affected skin conditions such as inflammatory acne. Current topical acne treatment options including benzoyl peroxide and retinoids can worsen the barrier dysfunctions by increasing transepidermal water loss, depleting SC vitamin E levels, and relatively decreasing SC thickness. However, strategies exist to employ these treatments in a more effective manner and lessen barrier function disruption including use of less irritating vehicles or concomitant application of moisturizers. Patients also play a role in the outcome of their skin barrier function based on their compliance and administration technique. By increasing patient compliance and proper application of treatments, patient skin barrier function can improve. Additionally, future treatments are on the horizon that may customize acne therapy at a molecular level. <br /><br /> <em>J Drugs Dermatol.</em> 2016;15(10):1170-1173.